Sign In
Buy RGEN
$149.78
+2.72 (+1.85%)
At Close: Aug 04, 2026
Repligen (RGEN) Q2 Earnings and Sales Beat Estimates, Stock Up
01:32pm, Wednesday, 03'rd Aug 2022
Repligen (RGEN) reports encouraging second-quarter results, with sales and earnings beating estimates. RGEN also raises its financial guidance for 2022
Why Shares Of Cannabis Companies Traded Higher; Here Are 101 Biggest Movers From Yesterday
10:07am, Wednesday, 03'rd Aug 2022 Benzinga
Gainers
MMTec, Inc. (NASDAQ: MTC) shares gained 390.6% to close at $7.85 on Tuesday amid volatility in nano-cap Chinese stocks.
Applied DNA Sciences, Inc. (NASDAQ: APDN) surged 296.9% to settle at $2
Uber, Lyft And Some Other Big Stocks Recording Gains On Tuesday
08:16am, Wednesday, 03'rd Aug 2022 Benzinga
U.S. stocks closed lower on Tuesday, with the Dow Jones dropping more than 400 points. Here is the list of some big stocks moving higher in the previous session.
AMTD IDEA Group (NYSE: AMTD) shares
Why Repligen Corporation Stock Is Storming Higher Today
06:56pm, Tuesday, 02'nd Aug 2022 The Motley Fool
Repligen's strong second-quarter results are a hit with investors.
Why Applied DNA Sciences Is Trading Higher By 166%, Here Are 75 Stocks Moving In Tuesday's Mid-Day Session
04:41pm, Tuesday, 02'nd Aug 2022 Benzinga
Gainers
AMTD IDEA Group (NYSE: AMTD) shares jumped 284% to $8.00 after jumping 18% on Monday. The company owns 90%+ of AMTD Digital.
Applied DNA Sciences, Inc. (NASDAQ: APDN) gained 166% to $1.8801
Why Repligen Corporation Stock Is Storming Higher Today
02:56pm, Tuesday, 02'nd Aug 2022
Repligen's strong second-quarter results are a hit with investors.
Repligen (RGEN) Tops Q2 Earnings and Revenue Estimates
12:45pm, Tuesday, 02'nd Aug 2022 Zacks Investment Research
Repligen (RGEN) delivered earnings and revenue surprises of 26.39% and 9.83%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
Is a Beat in Store for Gilead (GILD) in This Earnings Season?
02:10pm, Thursday, 28'th Jul 2022 Zacks Investment Research
Investors will focus on the HIV franchise's performance and Veklury sales in Gilead's (GILD) second-quarter 2022 results.
What's in the Cards for Sesen Bio's (SESN) Q2 Earnings?
04:00pm, Wednesday, 27'th Jul 2022 Zacks Investment Research
Sesen Bio's (SESN) Q2 performance is likely to reflect cost savings from the company's restructuring plans as the company continues to seek a potential partner for the further development of Vicineum.
Will Deciphera Pharmaceuticals, Inc. (DCPH) Report Negative Q2 Earnings? What You Should Know
02:01pm, Tuesday, 26'th Jul 2022 Zacks Investment Research
Deciphera Pharmaceuticals, Inc. (DCPH) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
What to Expect From Molina Healthcare's (MOH) Q2 Earnings?
03:35pm, Monday, 25'th Jul 2022 Zacks Investment Research
Molina Healthcare's (MOH) second-quarter results are likely to reflect benefits from higher premiums stemming from Medicaid and Medicare businesses, partly offset by elevated medical care costs.
Repligen (RGEN) Stock Jumps 15.3%: Will It Continue to Soar?
01:06pm, Friday, 22'nd Jul 2022 Zacks Investment Research
Repligen (RGEN) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the ro
Tesla, Danaher And Some Other Big Gainers From Yesterday
09:40am, Friday, 22'nd Jul 2022 Benzinga
U.S. stocks closed higher on Thursday, with the Nasdaq Composite jumping around 1.4%. Here is the list of some big stocks recording gains in the previous session.
Tabula Rasa HealthCare, Inc. (NASDAQ
This Healthcare Stock Jumped 110%; Here Are 64 Biggest Movers From Yesterday
09:04am, Friday, 22'nd Jul 2022 Benzinga
Gainers
Virax Biolabs Group Limited (NASDAQ: VRAX) shares climbed 264% to close at $18.20 on Thursday. The company offered shares at an expected price of $5.00 per share with an insider lock-up peri
Why Is Super Micro Computer Higher By More Than 13%? 42 Stocks Moving In Thursday's Mid-Day Session
04:33pm, Thursday, 21'st Jul 2022 Benzinga
Gainers
Virax Biolabs Group Limited (NASDAQ: VRAX) shares jumped 364.3% to $23.22. The company offered shares at an expected price of $5.00 per share with an insider lock-up period of 180 days endin
